Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

ISIS-23722 selected for clinical development

April 24, 2003

Initiation of phase I/II study of CG-7870 plus radiation in early-stage prostate cancer

April 24, 2003

Diatos licenses European rights for Super-Leu-Dox

April 24, 2003

Novel modulators of LPA receptors and their use in cancer, wound healing, etc.

April 24, 2003

Aventis scientists identify novel protein kinase inhibitors

April 24, 2003

Novel tyrosine kinase inhibitors under study at Merck & Co.

April 24, 2003

Three series of antitumor agents prepared and tested at Synta

April 24, 2003

AGI Dermatics regains rights to Dimericine

April 23, 2003

Phase II studies of ILX-651 planned

April 23, 2003

Northwest Biotherapeutics receives NCI grant for tumor growth inhibition

April 23, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...